Literature DB >> 7657025

Enhanced anticoagulant response to activated protein C in patients with IDDM.

W Krugluger1, H P Kopp, G Schernthaner, P Hopmeier.   

Abstract

Anticoagulant response to activated protein C (APC) was studied in 40 healthy subjects and 67 patients with insulin-dependent diabetes mellitus (IDDM) using a modified activated thromboplastin time assay. Results are expressed in terms of the APC sensitivity ratio (APC SR). In addition, plasma levels of protein C, total and free protein S (PS), coagulation factors V and VIII, and prothrombin fragment 1+2 (F1+2) were measured. Patients with IDDM and a urinary albumin excretion rate (UAER) < 30 mg/24 h showed a median APC SR of 2.5 (interquartile range 2.3-2.9). In patients with a UAER between 30 and 300 mg/24 h, the median APC SR was 2.7 (2.7-2.9). Both values were significantly greater than the median APC SR of 2.1 (2.0-2.5) observed in healthy control subjects (P < 0.001). Also, the percentage of subjects with an APC SR < or = 2.0 was markedly smaller in both patient groups. Factor V and VIII levels were not significantly different between IDDM patients and healthy subjects. Grouping of IDDM patients according to the APC SR revealed significantly enhanced levels of total PS (P < 0.05) and factor VIII (P < 0.01) in patients with a poor anticoagulant response to APC (APC SR < or = 2.0) compared with those with an APC SR > 2.7. The negative correlation of the APC SR in diabetic patients with both coagulation and anticoagulation factors indicates a complex role of this parameter in regulating the coagulation system in IDDM.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657025     DOI: 10.2337/diab.44.9.1033

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  4 in total

1.  Central venous catheter thrombosis complicated by paradoxical embolism in a patient with diabetic ketoacidosis and respiratory failure.

Authors:  John A Batsis; Iasmina M Craici; David A Froehling
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  An examination of the association between therapeutic anticoagulation control and glycemic control for patients with diabetes on oral anticoagulation therapy.

Authors:  Samuel G Johnson; Daniel M Witt; Thomas Delate; Melanie A Sadler
Journal:  J Thromb Thrombolysis       Date:  2005-06       Impact factor: 2.300

3.  Urinary albumin excretion is correlated to fibrinogen levels and protein S activity in patients with type 1 diabetes mellitus without overt diabetic nephropathy.

Authors:  Zoltán Lengyel; Péter Vörös; Lajos K Tóth; Csilla Németh; László Kammerer; Mária Mihály; László Tornóci; László Rosivall
Journal:  Wien Klin Wochenschr       Date:  2004-04-30       Impact factor: 1.704

4.  Effective INR Level May Be Delayed in Secondary Prevention of Stroke Due to Atrial Fibrillation with Warfarin in the Patients with Diabetes Mellitus.

Authors:  Türkan Acar; Yeşim Güzey Aras; Sıdıka Sinem Gül; Bilgehan Atilgan Acar
Journal:  Noro Psikiyatr Ars       Date:  2018-10-24       Impact factor: 1.339

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.